Hypertension: a cross-sectional study of the role of multimorbidity in blood pressure control

BMC Family Practice

Volumn 16, Issue 1, 2015, Pages

  Sarkar, Chandra ^a   Dodhia, Hiten ^b   Crompton, James ^b   Schofield, Peter ^a   White, Patrick ^a   Millett, Christopher ^c   Ashworth, Mark ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Lambeth Southwark Public Health Directorate   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; BLOOD PRESSURE MEASUREMENT; COMORBIDITY; CROSS-SECTIONAL STUDY; ENGLAND; FEMALE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; STATISTICAL MODEL; TREATMENT OUTCOME;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; LINEAR MODELS; LONDON; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84938808532     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/s12875-015-0313-y     Document Type: Article

References (36)

1. Salisbury C, Johnson L, Purdy S, Valderas JM, Montgomery AA. Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study. BJGP. 2011;61(582):e12-21.
2. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37-43.
3. Mathur R, Hull SA, Badrick E, Robson J. Cardiovascular multimorbidity: the effect of ethnicity on prevalence and risk factor management. BJGP. 2011;61(586):e262-70.
4. Fortin M, Stewart M, Poitras ME, Almirall J, Maddocks H. A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology. Ann Fam Med. 2012;10(2):142-51.
5. Smith SM, O'Dowd T. Chronic diseases: what happens when they come in multiples? BJGP. 2007;57(537):268-70.
6. Health and Social Care Information Centre. Disease Prevalence Quality and Outcomes Framework for April 2012-March2013, England. 2013 [cited 21/12/2013]. Available from: http://www.hscic.gov.uk/searchcatalogue?productid=12972&q=hypertension&sort=Relevance&size=10&page=1#top.
7. Health and Social Care Information Centre. Health Survey for England - 2012, Trend tables 2013 [cited 04/06/2014]. Available from: http://www.hscic.gov.uk/catalogue/PUB13219.
8. Schofield P, Baawuah F, Seed PT, Ashworth M. Managing hypertension in general practice: a cross-sectional study of treatment and ethnicity. BJGP. 2012;62(603):e703-9.
9. World Health Organisation. A global brief on hypertension. Silent killer, global public health crisis. Geneva: World Health Organisation; 2013.
10. Paulsen MS, Andersen M, Thomsen JL, Schroll H, Larsen PV, Lykkegaard J, et al. Multimorbidity and Blood Pressure Control in 37 651 Hypertensive Patients From Danish General Practice. Journal of the American Heart Association. 2013;2(1):e00453.
11. Millett C, Gray J, Bottle A, Majeed A. Ethnic disparities in blood pressure management in patients with hypertension after the introduction of pay for performance. Ann Fam Med. 2008;6(6):490-6.
12. Lund L, Jacobsen J, Nørgaard M, McLaughlin JK, Blot WJ, Borre M, et al. The prognostic impact of comorbidities on renal cancer, 1995 to 2006: a Danish population based study. J Urol. 2009;182(1):35-40.
13. Piccirillo JF, Vlahiotis A. Comorbidity in patients with cancer of the head and neck: prevalence and impact on treatment and prognosis. Curr Oncol Reports. 2006;8(2):123-9.
14. Glynn LG, Buckley B, Reddan D, Newell J, Hinde J, Dinneen SF, et al. Multimorbidity and risk among patients with established cardiovascular disease: a cohort study. Br J Gen Pract. 2008;58(552):488-94.
15. Austin RP. Polypharmacy as a risk factor in the treatment of type 2 diabetes. Diabetes Spectrum. 2006;19(1):13-6.
16. Bautista LE, Vera-Cala LM, Colombo C, Smith P. Symptoms of depression and anxiety and adherence to antihypertensive medication. Am J Hypertens. 2012;25(4):505-11.
17. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch Intern Med. 1993;153(5):598-615.
18. Department for communities and local government. English Indicies of deprivation 2010. England 2011. [cited 03/03/2014]. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/6871/1871208.pdf.
19. Office for National Statistics. 2011 Census: KS201UK Ethnic group, local authorities in the United Kingdom. 2011. Available from: http://www.ons.gov.uk/ons/datasets-and-tables/index.html?pageSize=50&sortBy=none&sortDirection=none&newquery=ethnic+lambeth.
20. Lambeth Council. 2012. State of the Borough Report. London: Lambeth Council.
21. IBM Corp. SPSS Statistics for Windows, Version 20.0. Armonk, NY: IBM Corp. Released 2011
22. Piette JD, Kerr EA. The Impact of Comorbid Chronic Conditions on Diabetes Care. Diabetes Care. 2006;29(3):725-31.
23. Lagu T, Weiner MG, Hollenbeak CS, Eachus S, Roberts CS, Schwartz JS, et al. The impact of concordant and discordant conditions on the quality of care for hyperlipidemia. J Gen Intern Med. 2008;23(8):1208-13.
24. Magnan EM, Palta M, Johnson HM, Bartels CM, Schumacher JR, Smith MA. The impact of a patient's concordant and discordant chronic conditions on diabetes care quality measures. J Diabetes Complications. 2014;29(2):288-9.
25. Kerr EA, Heisler M, Krein SL, Kabeto M, Langa KM, Weir D, et al. Beyond comorbidity counts: how do comorbidity type and severity influence diabetes patients' treatment priorities and self-management? J Gen Intern Med. 2007;22(12):1635-40.
26. Mathur R, Hull SA, Boomla K, Robson J. Ethnic differences in primary care management of diabetes and cardiovascular disease in people with serious mental illness. Brit J Gen Pract. 2012;62(601):e582-8. PubMed.
27. Ashworth M, Medina J, Morgan M. Effect of social deprivation on blood pressure monitoring and control in England: a survey of data from the quality and outcomes framework 2008 2008-10-29 01:00:42.
28. Khan NF, Harrison SE, Rose PW. Validity of diagnostic coding within the General Practice Research Database: a systematic review 2010 2010-03-01 00:00:00. e128-e36.
29. Burstyn P, O'Donovan B, Charlton I. Blood pressure variability: the effects of repeated measurement. Postgrad Med J. 1981;57(670):488-91.
30. Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH. HOw common is white coat hypertension? JAMA. 1988;259(2):225-8.
31. DiMatteo MR, Haskard KB, Williams SL. Health beliefs, disease severity, and patient adherence: a meta-analysis. Med Care. 2007;45(6):521-8. doi: 10.1097/MLR.0b013e318032937e.
32. Marshall IJ, Wolfe CD, McKevitt C. Lay perspectives on hypertension and drug adherence: systematic review of qualitative research. BMJ. 2012;345, e3953.
33. Mercer S, Salisbury C, Fortin M. 2014. ABC of Multimorbidity: John Wiley & Sons, London.
34. Health and Social Care Information Centre. Trends in Consultation Rates in General Practice - 1995-2009. 2009 [cited 20/06/2015]. Available from: http://www.hscic.gov.uk/pubs/gpcons95-09.
35. Guthrie B, Payne K, Alderson P, McMurdo MET, Mercer SW. Adapting clinical guidelines to take account of multimorbidity. BMJ. 2012 2012-10-04 12:03:03;345.
36. Payne RA, Abel GA, Guthrie B, Mercer SW. The effect of physical multimorbidity, mental health conditions and socioeconomic deprivation on unplanned admissions to hospital: a retrospective cohort study. Can Med Assoc J. 2013;185(5):E221-8.